🚨 Ohio Bans Hemp THC • Germany’s Surge • Trump’s Cannabis Slide

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

Today’s edition is brought to you by 1440 Media - the daily newsletter that covers the world’s stories in just five minutes. Click the links, stay curious, and get the full picture without the noise.

You may have noticed a light week for Decoded Insights lately. They take time to build, and we only publish them when there’s something worth unpacking in depth. When we see something, we’ll write something - and if you see a story that deserves a closer look, send it our way.

Ohio’s governor just used emergency powers to ban hemp-derived THC sales for 90 days, sending shockwaves through breweries, taprooms, and retailers who followed the rules. Missouri’s trade group lawyer is under scrutiny for writing the very contracts regulators are now calling predatory. And Germany’s medical market tripled in 18 months - a reminder that access, once opened, moves faster than regulators ever expect.

🚨 Ohio’s hemp emergency hits small operators
⚖️ Missouri’s predatory equity contracts exposed
🌿 Germany’s medical surge reshapes Europe

Start the day informed. Stay ahead.

📌 What Happened: Ohio Governor Mike DeWine issued an executive order on October 8 declaring a state of emergency to halt hemp-derived cannabinoid sales for 90 days, directing retailers to remove products from display by October 14 or face $500 daily fines, with state and local authorities empowered to seize inventory. The order cites the usual precursors to emergency actions: a 52% uptick in 2024 poison control cases involving children 12 and under exposed to intoxicating cannabinoids, with 90% requiring emergency room visits, and targets products packaged to look like popular candy brands. The Ohio Craft Brewers Association immediately pushed back, calling for reasonable regulation rather than a total ban and noting member breweries producing compliant low-dose hemp beverages already follow age verification and responsible service protocols in their taprooms. Toledo Spirits owner Andrew Newby said the ban eliminates his Delta-8 infused mocktails and argued the state should regulate rather than restrict, while hemp retailer Mark Fashian said the temporary prohibition "would basically put me out of business". The move follows California Governor Gavin Newsom and Texas Governor Greg Abbott taking similar executive approaches, with Illinois Governor JB Pritzker signaling the same strategy.

💡 Why It Matters: DeWine's emergency declaration bypasses normal rulemaking procedures after 20 months of failed legislative action, with stalled bills explicitly carving out low-dose drinkable cannabinoid products for liquor-licensed retailers while banning other intoxicating hemp from non-dispensary venues. The blanket ban treats Urban Artifact's age-gated taproom sales identically to gas stations selling candy-mimicking gummies to teenagers, catching legitimate operators who anticipated regulation rather than prohibition. House Speaker Matt Huffman suggested the emergency order might actually help force legislative compromise before Thanksgiving recess, while Representative Tex Fischer argued DeWine is targeting an entire industry over bad actors and questioned the governor's authority to act unilaterally. The craft brewing industry contributes $1.29 billion to Ohio's economy with hemp beverages providing crucial revenue as traditional beer consumption collapsed, leaving 10% of Ohio breweries permanently closed in 2022-2023. DeWine plans to redefine hemp in Ohio's administrative code to exclude intoxicating products and task the Department of Agriculture with adopting cultivation regulations, essentially legislating through emergency powers after admitting in January 2024 his lawyers didn't believe he had this authority until they "revisited the issue".

🌾 New York's Croptober Fraud Problem Shows License Stacking Breaks Markets

Damian Fagon, former New York cannabis regulator now at Parabola Center, published an op-ed detailing how New York quarantined $10 million in products during spring 2025 inversion probes but won't have full Metrc tracking until late December, giving this harvest season massive runway for out-of-state cannabis to get rebranded as local product. He describes how licensed operators pad harvest reports with fake disposals, then log cheap California or Michigan flower under inflated totals and sell it as New York-grown while compliant local harvests sit unsold, with California's legal sales falling 11% year-over-year as oversupply spills into New York and Michigan licensing 3.2 million plants by June - more than 1.5 plants per consumer. Fagon argues Metrc can't catch fraud entered as fact: the system stops licensed cannabis from leaking out but can't detect illicit supply typed in as compliant, which means physical audits matching reported yields to actual capacity are the only real enforcement mechanism. His thesis is that California and Michigan broke their markets through license stacking and unlimited consolidation, collapsing their own sales for four consecutive years while exporting chaos that neighboring states now absorb, and Pennsylvania and Virginia need to avoid repeating those structural defects. (Marijuana Moment)

⚖️ Missouri's Trade Group Lawyer Wrote the Predatory Contracts He's Now Defending

Eric Walter, general counsel for Missouri Cannabis Trade Association, drafted 22 contracts that state regulators say transferred microbusiness licenses from eligible applicants to well-connected investors, leading to all 22 license revocations now under appeal. Walter also sat on the committee that drafted Missouri's 2022 legalization amendment creating the microbusiness program, which requires licenses be "majority owned and operated" by eligible applicants - the same constitutional language his contracts are accused of violating. The agreements gave applicants two years to repay loans up to $2 million or pay break-up fees reaching $2.5 million, with three-member boards where applicants held just one vote, and regulators argue the business structure made revenue generation impossible, leaving ownership transfer as the only realistic outcome. Walter's clients include consulting firms led by MoCann board members David Brodsky and Scott Wootton, plus Arizona investor Michael Halow, who's connected to 16 of the 22 revoked licenses and previously faced Arizona lawsuits for taking over social-equity licenses without applicant knowledge. Nimrod Chapel, attorney and Missouri NAACP president, called the agreements "a trick" resulting in eligible applicants "receiving little to nothing," while former Missouri Supreme Court Chief Justice Mike Wolff said the state has a serious revocation argument. Cannabis is a small industry where attorney-investor-trade association overlap is common, but Missouri's equity program collision exposes the structural impossibility of prioritizing populations with the least capital access in an industry requiring millions in startup costs - legitimate financing looks nearly identical to predatory control transfer when applicants can't generate revenue fast enough to avoid ownership conversion, and Walter's dual role drafting both the constitutional requirements and the contracts accused of violating them just makes the contradiction more visible. (Missouri Independent)

🏢 Maryland Reopens Cannabis Incubator Site Search After Catonsville Blowback

Maryland opened applications for sites to host the nation's first state-run cannabis incubator after Governor Wes Moore scrapped plans to locate the $7 million project at Catonsville Armory following community opposition over proximity to schools and residential neighborhoods. The incubator will support social equity micro-licensees with technical assistance, programming, and workspace for up to 110 businesses storing or processing cannabis, funded through $2 million in fiscal 2025 and $5 million in fiscal 2026 appropriations. Moore directed the Maryland Cannabis Administration, Department of General Services, and Maryland Economic Development Corporation to identify new locations away from schools and residential communities after a Change.org petition and local officials raised concerns about security, traffic, and lack of early community engagement. The state originally reviewed 37 potential sites in December 2023 before selecting Catonsville, which drew backlash from residents who supported legalization but opposed what one father called "an undefined experiment" next to elementary schools and day cares. Maryland's restart of site selection after budget approval and initial location choice shows what happens when equity program implementation meets NIMBY politics - the $7 million appropriation survives because legislators support the concept, but execution becomes a multi-year process of finding communities willing to host what's essentially subsidized cannabis business infrastructure, which is why most states skip physical incubators entirely and just cut checks. (Baltimore Sun)

🏥 Germany's Medical Cannabis Market Tripled Through Telemedicine After April Reform

Germany's medical cannabis patient population tripled from roughly 250,000 to between 1-1.2 million in the 18 months after April 2024's Cannabis Act removed marijuana from the narcotic substances list, with telemedicine driving growth that surprised even experienced operators. Grunhorn CEO Stefan Fritsch said his company's patient count jumped 146% in the first year and nobody expected the day-one surge when CanG passed, with teleclinics launching immediately and overwhelming systems built for gradual adoption. The explosion exposed tensions over whether providers are delivering genuine medical care or just processing prescription requests, with political backlash building against high-volume clinics rather than telemedicine platforms themselves. Fritsch expects consolidation to favor operators with established doctor networks over pure-play teleclinics optimized for throughput, noting Grunhorn maintained relationships with 7,000 physicians who lost patients to online clinics but could reconnect them if crackdowns hit. US states watching should note the pattern: remove Schedule I-style restrictions while enabling digital access and patient adoption accelerates far beyond projections, then regulators struggle to distinguish legitimate telemedicine from prescription mills and often threaten the entire platform rather than targeting bad actors specifically. (Business of Cannabis)